Influenza A H3N2

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Influenza A H3N2 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT06620185

GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

This experimental medicine study aims to compare immune responses in healthy adult volunteers aged 18-55 years against influenza vaccination and infection in th…

United Kingdom36 participantsStarted 2025-04-16

Treatment: FLUENZ, Influenza challenge virus

RecruitingPhase 1

NCT06753474

A/Texas Flu Challenge

This study is designed to help us better understand how the immune system responds to the flu and how flu is transmitted in the environment. The ultimate goal i…

United States50 participantsStarted 2025-02-04

Treatment: Influenza Virus influenza A H3N2 strain

All recent trials (33 shown)

CompletedNot Applicable

NCT06972810

Human Infection Study of H3N2 Influenza in Healthy Adults

This study will examine how the immune system responds to a flu virus (H3N2) during and after infection in health adults aged between 18 and 50 while in an inpa…

Australia11 participantsStarted 2025-05-05

Treatment: A/Texas/71/2017, clade 3C3a H3N2 influenza virus

Active — Not RecruitingPhase 3

NCT06087640

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a No…

This Phase 3 study is a randomized, observer-blind study of MF59-adjuvanted influenza vaccine (aQIV or aTIV) compared with a non-adjuvanted influenza vaccine (Q…

United States35,800 participantsStarted 2023-10-23

Treatment: aQIV or aTIV, QIV or TIV

Influenza A H3N2

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

A/Texas Flu Challenge

All recent trials (33 shown)

Human Infection Study of H3N2 Influenza in Healthy Adults

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a No…

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

A/Texas Flu Challenge

All recent trials (33 shown)

Human Infection Study of H3N2 Influenza in Healthy Adults

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a No…

Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge Strain

Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness

Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N…

Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine

Pilot Influenza Challenge Study

Single Dose Texas 2017 (H3N2) Challenge Study

A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A

Assessment of Wearable Sensors During Experimental Human Influenza Infection (Sigma Plus)

Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old

Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults

Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines

H3N2 M2SR in Pediatric Population

Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers

A Study to Determine the Safety and Attack Rate of the Seasonal Flu in Healthy Volunteers

Characterisation of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers

Study Examining PrEP-001 in Healthy Subjects